A 68-year-old woman with a 2-year history of bilateral vocal cord paralysis in paramedian position presents with progressive dyspnea and stridor. She has failed voice therapy. Which is the drug of choice for symptomatic relief of her dysphonia while awaiting surgical intervention?

Explanation

## Chronic Bilateral Vocal Cord Paralysis: Botulinum Toxin Role ### Clinical Context Bilateral vocal cord paralysis in paramedian position presents a dual challenge: 1. **Airway compromise** → stridor, dyspnea (surgical priority: tracheostomy or posterior cordotomy) 2. **Dysphonia** → voice quality impairment (medical/pharmacological management) This patient has failed voice therapy and faces a 2-year chronic course, placing her beyond the acute steroid window. Surgical airway management (tracheostomy or laser cordotomy) addresses the breathing problem; botulinum toxin addresses the dysphonia. ### Botulinum Toxin: Mechanism and Role **Key Point:** Botulinum toxin is the pharmacological drug of choice for symptomatic dysphonia in chronic vocal cord paralysis, particularly when bilateral involvement or spasticity complicates the picture. **Mechanism of Action:** - Blocks acetylcholine release at the neuromuscular junction - Reduces hypertonicity of paralyzed cord musculature - Improves voice quality by reducing strain and tremor - Injected into thyroarytenoid or lateral cricoarytenoid muscles ### Indications and Efficacy | Scenario | Drug | Indication | Outcome | |---|---|---|---| | Acute VCP (< 4 weeks) | Corticosteroids | Reduce edema, promote recovery | 60–70% spontaneous recovery | | Chronic VCP (> 3 months), unilateral | Vocal cord injection (calcium hydroxylapatite, hyaluronic acid) | Medialization | Voice improvement | | Chronic VCP, bilateral or spastic | Botulinum toxin | Reduce hypertonicity, improve dysphonia | 70–80% symptom relief | | Airway obstruction (bilateral paramedian) | Surgical (cordotomy, arytenoidectomy, tracheostomy) | Restore airway | Breathing restored | **Clinical Pearl:** In bilateral paramedian vocal cord paralysis, the patient typically has a patent but narrow airway (stridor) and poor voice. Botulinum toxin relaxes the paralyzed cords slightly, reducing stiffness and improving phonation without worsening airway (because the cords are already fixed in a near-closed position). Surgical intervention (posterior cordotomy or arytenoidectomy) remains the definitive airway solution. **High-Yield:** Botulinum toxin is NOT a cure—it is a temporizing measure (lasts 3–4 months per injection) that improves voice quality while the patient awaits or declines surgery. It is the only pharmacological option for chronic dysphonia in this setting. ### Why Not Corticosteroids? At 2 years post-onset, the acute inflammatory phase has passed. Steroids are ineffective in chronic, established paralysis and carry long-term side effects if used chronically. [cite:Harrison 21e Ch 32; Robbins & Cotran 10e Ch 16]